{"Title": ["Ex-Dividend Reminder: Cerner, C.H. Robinson Worldwide and Air Lease", "CERN Makes Bullish Cross Above Critical Moving Average", "Daily Dividend Report: APD,CERN,NEE,BLK,MPW", "First Week of July 17th Options Trading For Cerner", "How The Pieces Add Up: RYH Targets $236", "Nasdaq 100 Movers: AMD, UAL", "Cerner's Q1 Results and Future Outlook Weighed Down by Coronavirus Impact", "Cerner Corp (CERN) Q1 2020 Earnings Call Transcript", "Ex-Dividend Reminder: Cerner, C.H. Robinson Worldwide and Air Lease", "Cerner Q1 20 Earnings Conference Call At 4:30 PM ET", "S&P 500 Analyst Moves: CERN", "First Week of December 18th Options Trading For Cerner (CERN)", "Ex-Dividend Reminder: Cerner, Cisco Systems and Steelcase", "Cerner Enters Oversold Territory (CERN)", "How The Pieces Add Up: OVOL Targets $36", "Daily Dividend Report: UDR,INDB,CERN,BXP,MAA", "Cerner Corp Q1 adjusted earnings Beat Estimates", "Nasdaq 100 Movers: UAL, CERN", "Trump Administration Finalizes Major Data Sharing Rules for Healthcare Providers and Patients", "Cerner Enters Oversold Territory (CERN)", "Notable Two Hundred Day Moving Average Cross - CERN", "Nasdaq 100 Movers: CERN, CSGP", "CERN Crosses Above Average Analyst Target", "Health Care Sector Update for 02/05/2020: VVUS,CERN,AIMT,GILD", "Top 3 EHR Stock Picks", "Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD", "Nasdaq 100 Movers: TSLA, CERN", "Here's Why Investors Liked Cerner's Q4 Earnings Results", "CompuGroup To Buy Parts Of Cerner's IT Healthcare Portfolio In Germany, Spain", "Cerner Corp (CERN) Q4 2019 Earnings Call Transcript", "Cerner Corp Q4 adjusted earnings Beat Estimates", "At Davos, Alphabet's CEO Calls Healthcare the Major AI Opportunity", "Health Care Sector Update for 02/05/2020: CERN,AIMT,GILD", "Better Buy: Veeva Systems vs. Cerner", "First Week of CERN February 2020 Options Trading", "Ex-Dividend Reminder: Cerner, Kulicke & Soffa Industries and Regal Beloit", "Amazon Continues to Make Stealth Moves Into Healthcare", "Amazon Makes Another Big Move Into Healthcare", "Exclusive Interview: Livongo Health CEO on Chronic Illness, the U.S. Healthcare System, and Its Opportunity", "Analysts Anticipate RPG To Hit $133", "First Week of September 18th Options Trading For Cerner", "Cerner Corp (CERN) Q3 2019 Earnings Call Transcript", "Cerner Corp Q3 adjusted earnings Inline With Estimates", "Cerner Q3 19 Earnings Conference Call At 4:30 PM ET", "Notable Wednesday Option Activity: CERN, LNG, NTNX", "Insiders Bullish on Certain Holdings of DSI", "RSI Alert: Cerner (CERN) Now Oversold", "Noteworthy Wednesday Option Activity: CERN, POST, TTWO", "What You'll Want to Know About Cerner's Solid Q3 Results", "Where Will Veeva Systems Be in 5 Years?"], "Elapsed Time": ["2 DAYS AGO", "MAY 28, 2020", "MAY 22, 2020", "MAY 15, 2020", "MAY 1, 2020", "APR 29, 2020", "APR 29, 2020", "APR 29, 2020", "2 DAYS AGO", "APR 28, 2020", "APR 27, 2020", "APR 23, 2020", "MAR 31, 2020", "MAR 25, 2020", "MAR 25, 2020", "MAR 20, 2020", "APR 28, 2020", "MAR 12, 2020", "MAR 9, 2020", "FEB 28, 2020", "FEB 27, 2020", "FEB 12, 2020", "FEB 6, 2020", "FEB 5, 2020", "MAR 16, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 4, 2020", "FEB 4, 2020", "JAN 22, 2020", "FEB 5, 2020", "JAN 21, 2020", "DEC 24, 2019", "DEC 24, 2019", "DEC 14, 2019", "DEC 7, 2019", "NOV 27, 2019", "NOV 12, 2019", "JAN 22, 2020", "OCT 25, 2019", "OCT 24, 2019", "OCT 24, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 3, 2019", "OCT 2, 2019", "OCT 25, 2019", "SEP 21, 2019"], "Published Date": ["Jun 2, 2020 11:53AM EDT", "May 28, 2020 11:39AM EDT", "May 22, 2020 12:02PM EDT", "May 15, 2020 11:23AM EDT", "May 1, 2020 8:29AM EDT", "Apr 29, 2020 10:39AM EDT", "Apr 29, 2020 7:00AM EDT", "Apr 29, 2020 1:01AM EDT", "Jun 2, 2020 11:53AM EDT", "Apr 28, 2020 3:00PM EDT", "Apr 27, 2020 11:47AM EDT", "Apr 23, 2020 10:48AM EDT", "Mar 31, 2020 10:18AM EDT", "Mar 25, 2020 12:03PM EDT", "Mar 25, 2020 9:14AM EDT", "Mar 20, 2020 12:34PM EDT", "Apr 28, 2020 4:49PM EDT", "Mar 12, 2020 10:37AM EDT", "Mar 9, 2020 6:46PM EDT", "Feb 28, 2020 12:24PM EST", "Feb 27, 2020 4:41PM EST", "Feb 12, 2020 10:32AM EST", "Feb 6, 2020 9:24AM EST", "Feb 5, 2020 3:40PM EST", "Mar 16, 2020 3:35PM EDT", "Feb 5, 2020 1:59PM EST", "Feb 5, 2020 10:26AM EST", "Feb 5, 2020 7:00AM EST", "Feb 5, 2020 2:48AM EST", "Feb 4, 2020 11:32PM EST", "Feb 4, 2020 4:06PM EST", "Jan 22, 2020 4:49PM EST", "Feb 5, 2020 1:59PM EST", "Jan 21, 2020 3:36PM EST", "Dec 24, 2019 11:03AM EST", "Dec 24, 2019 10:00AM EST", "Dec 14, 2019 4:38PM EST", "Dec 7, 2019 8:00AM EST", "Nov 27, 2019 12:36PM EST", "Nov 12, 2019 8:12AM EST", "Jan 22, 2020 11:21AM EST", "Oct 25, 2019 12:24AM EDT", "Oct 24, 2019 5:09PM EDT", "Oct 24, 2019 3:02PM EDT", "Oct 23, 2019 3:18PM EDT", "Oct 23, 2019 9:37AM EDT", "Oct 3, 2019 12:00PM EDT", "Oct 2, 2019 3:19PM EDT", "Oct 25, 2019 6:00AM EDT", "Sep 21, 2019 7:00PM EDT"], "Link": ["https://www.nasdaq.com/articles/ex-dividend-reminder%3A-cerner-c.h.-robinson-worldwide-and-air-lease-2020-06-02", "https://www.nasdaq.com/articles/cern-makes-bullish-cross-above-critical-moving-average-2020-05-28", "https://www.nasdaq.com/articles/daily-dividend-report%3A-apdcernneeblkmpw-2020-05-22", "https://www.nasdaq.com/articles/first-week-of-july-17th-options-trading-for-cerner-2020-05-15", "https://www.nasdaq.com/articles/how-the-pieces-add-up%3A-ryh-targets-%24236-2020-05-01", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-amd-ual-2020-04-29", "https://www.nasdaq.com/articles/cerners-q1-results-and-future-outlook-weighed-down-by-coronavirus-impact-2020-04-29", "https://www.nasdaq.com/articles/cerner-corp-cern-q1-2020-earnings-call-transcript-2020-04-29", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-cerner-c.h.-robinson-worldwide-and-air-lease-2020-06-02", "https://www.nasdaq.com/articles/cerner-q1-20-earnings-conference-call-at-4%3A30-pm-et-2020-04-28", "https://www.nasdaq.com/articles/sp-500-analyst-moves%3A-cern-2020-04-27", "https://www.nasdaq.com/articles/first-week-of-december-18th-options-trading-for-cerner-cern-2020-04-23", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-cerner-cisco-systems-and-steelcase-2020-03-31", "https://www.nasdaq.com/articles/cerner-enters-oversold-territory-cern-2020-03-25", "https://www.nasdaq.com/articles/how-the-pieces-add-up%3A-ovol-targets-%2436-2020-03-25", "https://www.nasdaq.com/articles/daily-dividend-report%3A-udrindbcernbxpmaa-2020-03-20", "https://www.nasdaq.com/articles/cerner-corp-q1-adjusted-earnings-beat-estimates-2020-04-28", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ual-cern-2020-03-12", "https://www.nasdaq.com/articles/trump-administration-finalizes-major-data-sharing-rules-for-healthcare-providers-and", "https://www.nasdaq.com/articles/cerner-enters-oversold-territory-cern-2020-02-28", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-cern-2020-02-27", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-cern-csgp-2020-02-12", "https://www.nasdaq.com/articles/cern-crosses-above-average-analyst-target-2020-02-06", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-vvuscernaimtgild-2020-02-05", "https://www.nasdaq.com/articles/top-3-ehr-stock-picks-2020-03-16", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-cernaimtgild-2020-02-05", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-tsla-cern-2020-02-05", "https://www.nasdaq.com/articles/heres-why-investors-liked-cerners-q4-earnings-results-2020-02-05", "https://www.nasdaq.com/articles/compugroup-to-buy-parts-of-cerners-it-healthcare-portfolio-in-germany-spain-2020-02-05", "https://www.nasdaq.com/articles/cerner-corp-cern-q4-2019-earnings-call-transcript-2020-02-05", "https://www.nasdaq.com/articles/cerner-corp-q4-adjusted-earnings-beat-estimates-2020-02-04", "https://www.nasdaq.com/articles/at-davos-alphabets-ceo-calls-healthcare-the-major-ai-opportunity-2020-01-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-02-05-2020%3A-cernaimtgild-2020-02-05-0", "https://www.nasdaq.com/articles/better-buy%3A-veeva-systems-vs.-cerner-2020-01-21", "https://www.nasdaq.com/articles/first-week-of-cern-february-2020-options-trading-2019-12-24", "https://www.nasdaq.com/articles/ex-dividend-reminder%3A-cerner-kulicke-soffa-industries-and-regal-beloit-2019-12-24", "https://www.nasdaq.com/articles/amazon-continues-to-make-stealth-moves-into-healthcare-2019-12-14", "https://www.nasdaq.com/articles/amazon-makes-another-big-move-into-healthcare-2019-12-07", "https://www.nasdaq.com/articles/exclusive-interview%3A-livongo-health-ceo-on-chronic-illness-the-u.s.-healthcare-system-and", "https://www.nasdaq.com/articles/analysts-anticipate-rpg-to-hit-%24133-2019-11-12", "https://www.nasdaq.com/articles/first-week-of-september-18th-options-trading-for-cerner-2020-01-22", "https://www.nasdaq.com/articles/cerner-corp-cern-q3-2019-earnings-call-transcript-2019-10-25", "https://www.nasdaq.com/articles/cerner-corp-q3-adjusted-earnings-inline-with-estimates-2019-10-24", "https://www.nasdaq.com/articles/cerner-q3-19-earnings-conference-call-at-4%3A30-pm-et-2019-10-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-cern-lng-ntnx-2019-10-23", "https://www.nasdaq.com/articles/insiders-bullish-on-certain-holdings-of-dsi-2019-10-23", "https://www.nasdaq.com/articles/rsi-alert%3A-cerner-cern-now-oversold-2019-10-03", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-cern-post-ttwo-2019-10-02", "https://www.nasdaq.com/articles/what-youll-want-to-know-about-cerners-solid-q3-results-2019-10-25", "https://www.nasdaq.com/articles/where-will-veeva-systems-be-in-5-years-2019-09-21"], "Content": ["Looking at the universe of stocks we cover at Dividend Channel, on 6/4/20, Cerner Corp. (Symbol: CERN), C.H. Robinson Worldwide, Inc. (Symbol: CHRW), and Air Lease Corp (Symbol: AL) will all trade ex-dividend for their respective upcoming dividends.  Cerner Corp. will pay its quarterly dividend of $0.18 on 7/17/20, C.H. Robinson Worldwide, Inc. will pay its quarterly dividend of $0.51 on 6/30/20, and Air Lease Corp will pay its quarterly dividend of $0.15 on 7/9/20.  \n\nAs a percentage of CERN's recent stock price of $72.59, this dividend works out to approximately 0.25%, so look for shares of Cerner Corp. to trade 0.25% lower \u2014 all else being equal \u2014 when CERN shares open for trading on 6/4/20.  Similarly, investors should look for CHRW to open 0.63% lower in price and for AL to open 0.48% lower, all else being equal.\n\n\n\n\n\nBelow are dividend history charts for CERN, CHRW, and AL, showing historical dividends prior to the most recent ones declared.\n\nCerner Corp. (Symbol: CERN):\nEND", "In trading on Thursday, shares of Cerner Corp. (Symbol: CERN) crossed above their 200 day moving average of $69.40, changing hands as high as $70.78 per share.  Cerner Corp. shares are currently trading up about 3.4% on the day.  The chart below shows the one year performance of CERN shares, versus its 200 day moving average:\n\n   END", "\nThe Board of Directors of Air Products today declared a quarterly dividend of $1.34 per share of common stock. The dividend is payable on August 10, 2020 to shareholders of record at the close of business on July 1, 2020.\n\nCerner, a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will be payable on July 17, 2020, to shareholders of record as of the close of business on June 5, 2020.\n\nThe board of directors of NextEra Energytoday declared a regular quarterly common stock dividend of $1.40 per share. The dividend is payable on June 15, 2020, to shareholders of record on June 2, 2020. \n\nBlackRock today announced that its Board of Directors has declared a quarterly cash dividend of $3.63 per share of common stock, payable June 23, 2020 to shareholders of record at the close of business on June 5, 2020.\nEND", "Investors in Cerner Corp. (Symbol: CERN) saw new options become available this week, for the July 17th expiration.   At Stock Options Channel, our YieldBoost formula has looked up and down the CERN options chain for the new July 17th contracts and identified one put and one call contract of particular interest.The put contract at the $62.50 strike price has a current bid of $2.35.  If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $62.50, but will also collect the premium, putting the cost basis of the shares at $60.15 (before broker commissions).  To an investor already interested in purchasing shares of CERN, that could represent an attractive alternative to paying $65.16/share today.\n\nBecause the $62.50 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless.  The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 66%.  Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract.  Should the contract expire worthless, the premium would represent a 3.76% return on the cash commitment, or 21.78% annualized \u2014 at Stock Options Channel we call this the YieldBoost.\n\n\nBelow is a chart showing the trailing twelve month trading history for Cerner Corp., and highlighting in green where the $62.50 strike is located relative to that history:\n\nEND", "Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. \tFor the Invesco S&P 500\u2014 Equal Weight Health Care ETF (Symbol: RYH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $235.60 per unit.\n\n\nWith RYH trading at a recent price near $214.53 per unit, that means that analysts see 9.82% upside for this ETF looking through to the average analyst targets of the underlying holdings.   Three of RYH's underlying holdings with notable upside to their analyst target prices are DENTSPLY SIRONA Inc (Symbol: XRAY), Abbott Laboratories (Symbol: ABT), and Cerner Corp. (Symbol: CERN). Although XRAY has traded at a recent price of $42.44/share, the average analyst target is 19.64% higher at $50.78/share. Similarly, ABT has 12.66% upside from the recent share price of $92.09 if the average analyst target price of $103.75/share is reached, and analysts on average are expecting CERN to reach a target price of $78.16/share, which is 12.63% above the recent price of $69.39. Below is a twelve month price history chart comparing the stock performance of XRAY, ABT, and CERN:  \n\n END", "In early trading on Wednesday, shares of United Airlines Holdings topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.0%.  Year to date, United Airlines Holdings has lost about 65.5% of its value.\n\nAnd the worst performing Nasdaq 100 component thus far on the day is Advanced Micro Devices, trading down 3.4%.  Advanced Micro Devices is showing a gain of 16.9% looking at the year to date performance.\n\nTwo other components making moves today are Cerner, trading down 2.0%, and Alphabet, trading up 7.8% on the day.\n\n \n\n\n\n\n\n\n\nVIDEO: Nasdaq 100 Movers: AMD, UAL\nEND", "In most years, a 2% year-to-date decline for a stock by late April wouldn't be viewed as a good thing. That's what\u00a0Cerner\u00a0(NASDAQ: CERN) stock has delivered so far in 2020. But considering the upheaval brought by the COVID-19 pandemic, many investors probably aren't disgruntled with Cerner's performance.Cerner announced its first-quarter results after the market closed on Tuesday. And the healthcare technology provider gave reasons for shareholders to be both disgruntled and gruntled.\u00a0Here are the highlights of Cerner's Q1 update.END", "END", "Looking at the universe of stocks we cover at Dividend Channel, on 6/4/20, Cerner Corp. (Symbol: CERN), C.H. Robinson Worldwide, Inc. (Symbol: CHRW), and Air Lease Corp (Symbol: AL) will all trade ex-dividend for their respective upcoming dividends.  Cerner Corp. will pay its quarterly dividend of $0.18 on 7/17/20, C.H. Robinson Worldwide, Inc. will pay its quarterly dividend of $0.51 on 6/30/20, and Air Lease Corp will pay its quarterly dividend of $0.15 on 7/9/20.  \n\nAs a percentage of CERN's recent stock price of $72.59, this dividend works out to approximately 0.25%, so look for shares of Cerner Corp. to trade 0.25% lower \u2014 all else being equal \u2014 when CERN shares open for trading on 6/4/20.  Similarly, investors should look for CHRW to open 0.63% lower in price and for AL to open 0.48% lower, all else being equal.\n\n\n\n\n\nBelow are dividend history charts for CERN, CHRW, and AL, showing historical dividends prior to the most recent ones declared.\n\nCerner Corp. (Symbol: CERN):\nEND", "(RTTNews) - Cerner Corp. (CERN) will host a conference call at 4:30 PM ET on April 28, 2020, to discuss Q1 20 earnings results.To access the live webcast, log on to https://investors.cerner.com/events-and-presentationsTo listen to the call, dial (678) 509-7542; Passcode Cerner. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.END", "The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Cerner is now the #52 analyst pick, moving up by 26 spots.\n\nThis rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.\n\nLooking at the stock price movement year to date, Cerner is lower by about 0.5%.\n\n \n\n\n\n\n\n\n\nVIDEO: S&P 500 Analyst Moves: CERN\nEND", "Investors in Cerner Corp. (Symbol: CERN) saw new options become available this week, for the December 18th expiration.  One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.   At Stock Options Channel, our YieldBoost formula has looked up and down the CERN options chain for the new December 18th contracts and identified one put and one call contract of particular interest.The put contract at the $70.00 strike price has a current bid of $6.90.  If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $70.00, but will also collect the premium, putting the cost basis of the shares at $63.10 (before broker commissions).  To an investor already interested in purchasing shares of CERN, that could represent an attractive alternative to paying $71.45/share today.\n\nBecause the $70.00 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless.  The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 58%.  Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract.  Should the contract expire worthless, the premium would represent a 9.86% return on the cash commitment, or 15.05% annualized \u2014 at Stock Options Channel we call this the YieldBoost.\n\n\nBelow is a chart showing the trailing twelve month trading history for Cerner Corp., and highlighting in green where the $70.00 strike is located relative to that history:\n\nEND", "Looking at the universe of stocks we cover at Dividend Channel, on 4/2/20, Cerner Corp. (Symbol: CERN), Cisco Systems Inc (Symbol: CSCO), and Steelcase, Inc. (Symbol: SCS) will all trade ex-dividend for their respective upcoming dividends.  Cerner Corp. will pay its quarterly dividend of $0.18 on 4/17/20, Cisco Systems Inc will pay its quarterly dividend of $0.36 on 4/22/20, and Steelcase, Inc. will pay its quarterly dividend of $0.07 on 4/17/20.  \n\nAs a percentage of CERN's recent stock price of $63.72, this dividend works out to approximately 0.28%, so look for shares of Cerner Corp. to trade 0.28% lower \u2014 all else being equal \u2014 when CERN shares open for trading on 4/2/20.  Similarly, investors should look for CSCO to open 0.90% lower in price and for SCS to open 0.66% lower, all else being equal.\n\n\n\n\n\nBelow are dividend history charts for CERN, CSCO, and SCS, showing historical dividends prior to the most recent ones declared.\n\nCerner Corp. (Symbol: CERN):\nEND", "Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.  One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.  A stock is considered to be oversold if the RSI reading falls below 30.\n\nIn trading on Wednesday, shares of Cerner Corp. (Symbol: CERN) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $56.94 per share.  By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 38.9.  A bullish investor could look at CERN's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.    The chart below shows the one year performance of CERN shares:\n   \n   END", "Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. \tFor the Invesco Russell 1000\u2014Low Volatility Factor ETF (Symbol: OVOL), we found that the implied analyst target price for the ETF based upon its underlying holdings is $36.41 per unit.\n\n\nWith OVOL trading at a recent price near $27.30 per unit, that means that analysts see 33.33% upside for this ETF looking through to the average analyst targets of the underlying holdings.   Three of OVOL's underlying holdings with notable upside to their analyst target prices are Crown Castle International Corp (Symbol: CCI), Cerner Corp. (Symbol: CERN), and Dominion Energy Inc (Symbol: D). Although CCI has traded at a recent price of $123.71/share, the average analyst target is 36.00% higher at $168.25/share. Similarly, CERN has 35.51% upside from the recent share price of $58.42 if the average analyst target price of $79.17/share is reached, and analysts on average are expecting D to reach a target price of $88.28/share, which is 34.44% above the recent price of $65.67. Below is a twelve month price history chart comparing the stock performance of CCI, CERN, and D:  \n\n END", "UDR, a leading multifamily real estate investment trust, today announced that its Board of Directors declared a regular quarterly dividend on its common stock for the first quarter of 2020 in the amount of $0.36 per share, payable in cash, on April 30, 2020 to UDR common stock shareholders of record as of April 10, 2020. The April 30 dividend will be the 190th consecutive quarterly dividend paid by the Company on its common stock.  As previously announced in February, the Company's annualized 2020 common dividend of $1.44 per share represents a 5.1% increase over the annualized common dividend of $1.37 per share in 2019. \n\nThe Board of Directors of Independent Bank, parent of Rockland Trust Company, today announced a $0.46 per share dividend. The dividend will be payable on April 9, 2020, to stockholders of record as of the close of business on March 30, 2020. \n\nCerner, a global health care technology company, today announced that its Board of Directors declared a cash dividend to stockholders of $0.18 per issued and outstanding share. The cash dividend will be payable on April 17, 2020, to shareholders of record as of the close of business on April 3, 2020.\n\nBoston Properties announced today that its Board of Directors declared a regular quarterly cash dividend of $0.98 per share of common stock for the period January 1, 2020 to March 31, 2020 payable on April 30, 2020 to shareholders of record as of the close of business on March 31, 2020. \nEND", "(RTTNews) - Cerner Corp (CERN) released a profit for first quarter that declined from last year.The company's bottom line totaled $147.16 million, or $0.47\t per share.  This compares with $166.22 million, or $0.51\t per share, in last year's first quarter.Excluding items, Cerner Corp reported adjusted earnings of $222.71 million or $0.71 per share for the period. Analysts had expected the company to earn $0.70 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.END", "In early trading on Thursday, shares of Cerner topped the list of the day's best performing components of the Nasdaq 100 index, trading down 1.3%.  Year to date, Cerner has lost about 8.1% of its value.\n\nAnd the worst performing Nasdaq 100 component thus far on the day is United Airlines Holdings, trading down 14.5%.  United Airlines Holdings is lower by about 52.1% looking at the year to date performance.\n\nTwo other components making moves today are Expedia Group, trading down 13.9%, and Incyte, trading down 1.5% on the day.\n\n \n\n\n\n\n\n\n\nVIDEO: Nasdaq 100 Movers: UAL, CERN\nEND", "The Trump administration finalized two highly anticipated rules regarding healthcare data sharing that are expected to make it easier for patients to access, download, and store their medical information..The Department of Health and Human Services (HHS) issued two rules to improve access to medical data as part of the bipartisan 21st\u00a0Century Cures Act. These rules would compel insurers and hospitals to make patients' healthcare information easily shareable by modern technological standards. The idea is that once these rules are in place, patients will be able to store and share their medical records on their own devices.END", "Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.  One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.  A stock is considered to be oversold if the RSI reading falls below 30.\n\nIn trading on Friday, shares of Cerner Corp. (Symbol: CERN) entered into oversold territory, hitting an RSI reading of 28.0, after changing hands as low as $67.91 per share.  By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 17.1.  A bullish investor could look at CERN's 28.0 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.    The chart below shows the one year performance of CERN shares:\n   \n   END", "In trading on Thursday, shares of Cerner Corp. (Symbol: CERN) crossed below their 200 day moving average of $71.07, changing hands as low as $69.83 per share.  Cerner Corp. shares are currently trading down about 3.5% on the day.  The chart below shows the one year performance of CERN shares, versus its 200 day moving average:\n\n   END", "\nIn early trading on Wednesday, shares of CoStar Group, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.0%.  Year to date, CoStar Group, registers a 19.5% gain.\n\nAnd the worst performing Nasdaq 100 component thus far on the day is Cerner, trading down 2.7%.  Cerner is showing a gain of 6.4% looking at the year to date performance.\n\nTwo other components making moves today are Gilead Sciences, trading down 1.8%, and Micron Technology, trading up 6.3% on the day.\n\n \n\n\n\n\n\n\n\nVIDEO: Nasdaq 100 Movers: CERN, CSGP\nEND", "\nThere are 15 different analyst targets contributing to that average for Cerner Corp., but the average is just that \u2014 a mathematical average.  There are analysts with lower targets than the average, including one looking for a price of $62.00.  And then on the other side of the spectrum one analyst has a target as high as $85.00.  The standard deviation is $7.091.\n\n\nBut the whole reason to look at the average CERN price target in the first place is to tap into a \"wisdom of crowds\" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes.  And so with CERN crossing above that average target price of $76.90/share, investors in CERN have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $76.90 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table?  Below is a table showing the current thinking of the analysts that cover Cerner Corp.:\n\n\nEND", "Top Health Care StocksJNJ\t+1.14%PFE\t+1.25%ABT\t+1.53%MRK\t-3.28%AMGN\t+4.93%Health care stocks were sharply higher, with the NYSE Health Care Index rising 1.5% this afternoon while the shares of health care companies in the S&P 500 also were up 1.9% as a group. The Nasdaq Biotechnology index also was climbing 2.6%.Among health care stocks moving on news:(+) Vivus (VVUS) rallied on Wednesday, at one point pushing out to a 73% advance after US regulators approved the company's supplemental new drug application for a delayed-release formulation of its pancreaze prescription medicine used to treat people who cannot digest food normally due to pancreas disorders. According to Vivus the new formulation extends its shelf life up to 36 months across and will reduce the out-of-pocket costs for patients.In other sector news:(+) Cerner (CERN) rose almost 6% after the health care information technology company reported non-GAAP Q4 net income of $0.75 per share, improving on a $0.63 per share adjusted profit during the same quarter last year and beating the Capital IQ consensus by $0.01 per share. Revenue rose to $1.44 billion from $1.37 billion a year ago, topping the $1.43 billion Street view.(+) Aimmune Therapeutics (AIMT) climbed 3.2% on Wednesday after saying Nestle Health Science was making an additional $200 million equity investment in the biopharmaceuticals company, boosting its total investment to $473 million.END", "In this episode of Industry Focus: Wildcard, Motley Fool analyst Dylan Lewis and contributor Brian Feroldi bring you three promising electronic health record (EHR) stocks. What does the market look like right now? What are the incentives for doctors and consumers? How are the companies positioning themselves and evolving their strategies.To catch full episodes of all The Motley Fool's free podcasts, check out our\u00a0podcast center. To get started investing, check out our\u00a0quick-start guide to investing in stocks. A full transcript follows the video.10 stocks we like better than CernerWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*David and Tom just revealed what they believe are the ten best stocks for investors to buy right now\u2026 and Cerner wasn't one of them! That's right -- they think these 10 stocks are even better buys.END", "Top Health Care StocksJNJ\t+1.27%PFE\t+1.74%ABT\t+1.22%MRK\t-3.04%AMGN\t+5.50%Health care stocks were sharply higher, with the NYSE Health Care Index rising 1.5% in recent trade while the shares of health care companies in the S&P 500 also were up almost 2.2% as a group. The Nasdaq Biotechnology index also was climbing 3.6%.Among health care stocks moving on news:(+) Cerner (CERN) rose more than 6% after the health care information technology company reported non-GAAP Q4 net income of $0.75 per share, improving on a $0.63 per share adjusted profit during the same quarter last year and beating the Capital IQ consensus by $0.01 per share. Revenue rose to $1.44 billion from $1.37 billion a year ago, topping the $1.43 billion Street view.In other sector news:(+) Aimmune Therapeutics (AIMT) climbed 5.6% on Wednesday after saying Nestle Health Science was making an additional $200 million equity investment in the biopharmaceuticals company, boosting its total investment to $473 million.(-) Gilead Sciences (GILD) fell 1.5% after the specialty drugmaker reported below-consensus Q4 net income, earning $1.30 per share during the three months ended Dec. 31 and falling short of the $1.67 per share profit expected, on average, by analysts. Gilead shares also were facing resistance after the US patent office Wednesday said it's unlikely the company will win cases challenging the government ownership of the patents underlying HIV drugs.END", "In early trading on Wednesday, shares of Cerner topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.7%.  Year to date, Cerner registers a 8.9% gain.\n\nAnd the worst performing Nasdaq 100 component thus far on the day is Tesla, trading down 10.5%.  Tesla is showing a gain of 89.9% looking at the year to date performance.\n\nTwo other components making moves today are Take-Two Interactive Software, trading down 4.6%, and Microchip Technology, trading up 5.9% on the day.\n\n \n\n\n\n\n\n\n\nVIDEO: Nasdaq 100 Movers: TSLA, CERN\nEND", "Cerner (NASDAQ: CERN)\u00a0wowed investors in 2019 by racking up a 40% gain in share price. So far this year, though, there hasn't been much excitement from the big health information technology provider.But Cerner gave investors something to like when it announced its fourth-quarter results after the market closed on Tuesday. Here are the highlights of the company's Q4 update.END", "(RTTNews) - CompuGroup Medical SE (CMPVF.PK) and Cerner Corp. (CERN) have reached an agreement regarding the acquisition of parts of Cerner's IT Healthcare portfolio in Germany and Spain. The purchase price amounts to 225 million euros. The customer base of the acquired business includes 251 hospitals in Germany and 65 hospitals in Spain.Also, the Management Board and the Supervisory Board of CompuGroup Medical SE have resolved to propose to the shareholders' meeting a change of the legal form of the company into a partnership limited by shares. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.END", "END", "(RTTNews) - Cerner Corp (CERN) reported a profit for its fourth quarter that climbed from the same period last year.The company's earnings totaled $154.33 million, or $0.49 per share.  This compares with $131.32 million, or $0.40 per share, in last year's fourth quarter.Excluding items, Cerner Corp reported adjusted earnings of $237.18 million or $0.75 per share for the period. Analysts had expected the company to earn $0.74 per share, according to figures compiled by Thomson Reuters.  Analysts' estimates typically exclude special items.END", "During a panel discussion today at the World Economic Forum in Davos, Switzerland, Sundar Pichai, the CEO of Alphabet (NASDAQ: GOOG) shared some upbeat thoughts on how AI and healthcare could intersect.\u00a0\"Cancer [is] often missed and the difference in outcome is profound,\" he said, according to Reuters. \"In lung cancer, for example, five experts agree this way and five agree the other way. We know we can use artificial intelligence to make it better.\"\u00a0\u00a0\u00a0Two years ago at the 2018 Davos conference, Pichai said, \"A.I. is probably the most important thing humanity has ever worked on\" -- more profound, he said, than electricity or fire. But many observers worry about who will control artificial intelligence, and how it might be used in harmful ways -- for instance, to spy on people. And the concerns about the damage this technology could do to privacy are growing more intense as Alphabet and other tech giants move into the medical space, and seek access to our health information and data.END", "Top Health Care StocksJNJ\t+1.27%PFE\t+1.74%ABT\t+1.22%MRK\t-3.04%AMGN\t+5.50%Health care stocks were sharply higher, with the NYSE Health Care Index rising 1.5% in recent trade while the shares of health care companies in the S&P 500 also were up almost 2.2% as a group. The Nasdaq Biotechnology index also was climbing 3.6%.Among health care stocks moving on news:(+) Cerner (CERN) rose more than 6% after the health care information technology company reported non-GAAP Q4 net income of $0.75 per share, improving on a $0.63 per share adjusted profit during the same quarter last year and beating the Capital IQ consensus by $0.01 per share. Revenue rose to $1.44 billion from $1.37 billion a year ago, topping the $1.43 billion Street view.In other sector news:(+) Aimmune Therapeutics (AIMT) climbed 5.6% on Wednesday after saying Nestle Health Science was making an additional $200 million equity investment in the biopharmaceuticals company, boosting its total investment to $473 million.(-) Gilead Sciences (GILD) fell 1.5% after the specialty drugmaker reported below-consensus Q4 net income, earning $1.30 per share during the three months ended Dec. 31 and falling short of the $1.67 per share profit expected, on average, by analysts. Gilead shares also were facing resistance after the US patent office Wednesday said it's unlikely the company will win cases challenging the government ownership of the patents underlying HIV drugs.END", "Veeva Systems (NYSE: VEEV) and Cerner (NASDAQ: CERN) offer investors some unique opportunities to invest not only in healthcare but in technology as well. These two stocks can give investors the best of both worlds -- growth and stability. But deciding between the two is no easy task, as investors will need to determine just how much growth they're looking for versus how much stability they require.END", "Investors in Cerner Corp. (Symbol: CERN) saw new options begin trading this week, for the February 2020 expiration.   At Stock Options Channel, our YieldBoost formula has looked up and down the CERN options chain for the new February 2020 contracts and identified one put and one call contract of particular interest.The put contract at the $72.50 strike price has a current bid of $2.25.  If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $72.50, but will also collect the premium, putting the cost basis of the shares at $70.25 (before broker commissions).  To an investor already interested in purchasing shares of CERN, that could represent an attractive alternative to paying $73.36/share today.\n\nBecause the $72.50 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless.  The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 58%.  Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract.  Should the contract expire worthless, the premium would represent a 3.10% return on the cash commitment, or 19.20% annualized \u2014 at Stock Options Channel we call this the YieldBoost.\n\n\nBelow is a chart showing the trailing twelve month trading history for Cerner Corp., and highlighting in green where the $72.50 strike is located relative to that history:\n\nEND", "Looking at the universe of stocks we cover at Dividend Channel, on 12/26/19, Cerner Corp. (Symbol: CERN), Kulicke & Soffa Industries, Inc. (Symbol: KLIC), and Regal Beloit Corp (Symbol: RBC) will all trade ex-dividend for their respective upcoming dividends.  Cerner Corp. will pay its quarterly dividend of $0.18 on 1/9/20, Kulicke & Soffa Industries, Inc. will pay its quarterly dividend of $0.12 on 1/13/20, and Regal Beloit Corp will pay its quarterly dividend of $0.30 on 1/10/20.  \n\nAs a percentage of CERN's recent stock price of $73.26, this dividend works out to approximately 0.25%, so look for shares of Cerner Corp. to trade 0.25% lower \u2014 all else being equal \u2014 when CERN shares open for trading on 12/26/19.  Similarly, investors should look for KLIC to open 0.44% lower in price and for RBC to open 0.35% lower, all else being equal.\n\n\n\n\n\nBelow are dividend history charts for CERN, KLIC, and RBC, showing historical dividends prior to the most recent ones declared.\n\nCerner Corp. (Symbol: CERN):\nEND", "Back in September, Amazon.com (NASDAQ: AMZN) announced a new benefit for its workers. The pilot program -- called Amazon Care -- is a healthcare service being offered to the company's employees and their families in and around its Seattle headquarters. The program provides a number of innovative offerings, including both in-person and virtual options, while offering patients follow-up care and prescription drug delivery.While the nascent program might not seem particularly noteworthy, anyone who's followed the company for any length of time knows that Amazon has a history of developing products and services for in-house use at the company, only to offer them to customers and businesses later on.More importantly, this is just one in a number of recent moves that form a clear pattern that should put the industry on notice that Amazon's coming -- and it could mark the beginning of a dramatic shift in how healthcare is done.END", "Amazon.com\u00a0(NASDAQ: AMZN) is always looking for ways to innovate and achieve incremental growth, and the company has shown it isn't afraid to disrupt other industries to do so.Focusing on sectors outside e-commerce not only adds diversification but makes the stock a safer long-term buy. Healthcare, in particular, is a significant opportunity for technological advancements, and it's one area where Amazon could become a significant player in the years to come.END", "More than\u00a0147 million Americans have at least one chronic medical condition. Unfortunately, the U.S. healthcare system is not designed to provide these patients with the continual care that they need. This forces many of them to manage their condition on their own with limited guidance.Livongo Health (NASDAQ: LVGO) says it's on a mission \"to empower people with chronic conditions to live better and healthier lives.\" The company created a platform that uses\u00a0data science and technology to provide\u00a0personalized coaching to patients in real-time. Livongo calls these interactions \"health nudges,\" and it has the data to prove that they lead patients to make smarter health choices that drive behavior changes, improve clinical outcomes, and lower healthcare costs.END", "Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. \tFor the Invesco S&P 500\u2014 Pure Growth ETF (Symbol: RPG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $132.80 per unit.\n\n\nWith RPG trading at a recent price near $120.69 per unit, that means that analysts see 10.03% upside for this ETF looking through to the average analyst targets of the underlying holdings.   Three of RPG's underlying holdings with notable upside to their analyst target prices are Cerner Corp. (Symbol: CERN), Akamai Technologies Inc (Symbol: AKAM), and Pfizer Inc (Symbol: PFE). Although CERN has traded at a recent price of $66.26/share, the average analyst target is 14.48% higher at $75.86/share. Similarly, AKAM has 14.03% upside from the recent share price of $85.19 if the average analyst target price of $97.14/share is reached, and analysts on average are expecting PFE to reach a target price of $41.71/share, which is 12.95% above the recent price of $36.93. Below is a twelve month price history chart comparing the stock performance of CERN, AKAM, and PFE:  \n\n END", "Investors in Cerner Corp. (Symbol: CERN) saw new options begin trading this week, for the September 18th expiration.  One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.   At Stock Options Channel, our YieldBoost formula has looked up and down the CERN options chain for the new September 18th contracts and identified one put and one call contract of particular interest.The put contract at the $75.00 strike price has a current bid of $4.60.  If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $75.00, but will also collect the premium, putting the cost basis of the shares at $70.40 (before broker commissions).  To an investor already interested in purchasing shares of CERN, that could represent an attractive alternative to paying $76.25/share today.\n\nBecause the $75.00 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless.  The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 59%.  Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract.  Should the contract expire worthless, the premium would represent a 6.13% return on the cash commitment, or 9.33% annualized \u2014 at Stock Options Channel we call this the YieldBoost.\n\n\nBelow is a chart showing the trailing twelve month trading history for Cerner Corp., and highlighting in green where the $75.00 strike is located relative to that history:\n\nEND", "END", "(RTTNews) - Cerner Corp (CERN) revealed earnings for third quarter that fell from the same period last year.The company's bottom line came in at $81.94 million, or $0.26 per share.  This compares with $169.38 million, or $0.51 per share, in last year's third quarter.Excluding items, Cerner Corp reported adjusted earnings of $211.66 million or $0.66 per share for the period. Analysts had expected the company to earn $0.66 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.END", "(RTTNews) - Cerner Corp. (CERN) will host a conference call at 4:30 PM ET on Oct. 24, 2019, to discuss Q3 19 earnings results.To access the live webcast, log on to https://www.cerner.com/about/investor-relations/Presentations-and-WebcastsTo listen to the call, dial (678) 509-7542; Passcode Cerner. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.END", "Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cerner Corp. (Symbol: CERN), where a total volume of 8,649 contracts has been traded thus far today, a contract volume which is representative of approximately 864,900 underlying shares (given that every 1 contract represents 100 underlying shares).  That number works out to 48.9% of CERN's average daily trading volume over the past month, of 1.8 million shares.  Particularly high volume was seen for the $70 strike call option expiring November 15, 2019, with 2,362 contracts trading so far today, representing approximately 236,200 underlying shares of CERN.  Below is a chart showing CERN's trailing twelve month trading history, with the $70 strike highlighted in orange:\n\nEND", "\nCerner Corp. (Symbol: CERN), which makes up 0.17% of the iShares MSCI KLD 400 Social ETF (DSI), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.  The ETF holds a total of $2,632,893 worth of CERN, making it the #132 largest holding.  The table below details the recent insider buying activity observed at CERN:END", "Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful.  One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.  A stock is considered to be oversold if the RSI reading falls below 30.\n\nIn trading on Thursday, shares of Cerner Corp. (Symbol: CERN) entered into oversold territory, hitting an RSI reading of 28.2, after changing hands as low as $65.53 per share.  By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 38.5.  A bullish investor could look at CERN's 28.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side.    The chart below shows the one year performance of CERN shares:\n   \n   END", "Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cerner Corp. (Symbol: CERN), where a total of 10,907 contracts have traded so far, representing approximately 1.1 million underlying shares.  That amounts to about 62.2% of CERN's average daily trading volume over the past month of 1.8 million shares.  Particularly high volume was seen for the $72.50 strike call option expiring December 20, 2019, with 5,006 contracts trading so far today, representing approximately 500,600 underlying shares of CERN.  Below is a chart showing CERN's trailing twelve month trading history, with the $72.50 strike highlighted in orange:\n\nEND", "Cerner (NASDAQ: CERN) has quietly become a solid winner so far in 2019. Shares of the healthcare technology company are handily beating the broader market indexes. Cerner has met or beat Wall Street earnings expectations in recent quarters as well.The company announced its third-quarter results after the market closed on Thursday. And Cerner kept its streak going, meeting or beating analysts' estimates once again. Here are the highlights from Cerner's Q3 update.END", "Shares of life sciences technologist and software provider Veeva Systems (NYSE: VEEV) have been a big winner for the last few years. They've gained 400% over the last five-year stretch, and owning them has been one of the best ways to play the pharmaceuticals and biotech industry. \u00a0Even after an epic run, Veeva continues to put up solid double-digit sales growth and even faster profitability expansion, and the cloud-based software firm also reached a revenue milestone well ahead of schedule. On the heels of a recent software stock pullback and with digital transformation taking center stage, now looks like a good time to buy in or add to positions. There will be plenty of ways for Veeva Systems to grow even more in the next five years.END"]}